Publication | Open Access
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease
143
Citations
14
References
2021
Year
Chronic Inflammatory DiseasesCrohn ’ImmunologyGastroenterologyClinical GastroenterologyUlcerative ColitisMedicineRandomized Phase 2
| Year | Citations | |
|---|---|---|
Page 1
Page 1